{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137044777042944.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/med.20083"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.20083"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.20083"}}],"dc:title":[{"@value":"The evolution of progesterone receptor ligands"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:p>Progesterone is one of the first nuclear receptor hormones to be described functionally and subsequently approached as a drug target. Because progesterone (<jats:bold>1</jats:bold>) affects both menstruation and gestation <jats:italic>via</jats:italic> the progesterone receptor (PR), research aimed at modulating its activity is usually surrounded by controversy. However, ligands for PR were developed into drugs, and their evolution can be crudely divided into three periods: (1) drug‐like steroids that mimic the gestational properties of progesterone; (2) drug‐like steroids with different properties from progesterone and expanded therapeutic applications; and (3) non‐steroidal PR ligands with improved selectivity and modulator properties and further expanded therapeutic applications. Although the latter have yet to see widespread clinical applications, their development is founded on a half century of research, and they represent the future for this drug target. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 3, 374–400, 2007</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137044777043073","@type":"Researcher","foaf:name":[{"@value":"Kevin P. Madauss"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044777042944","@type":"Researcher","foaf:name":[{"@value":"Eugene L. Stewart"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044777043072","@type":"Researcher","foaf:name":[{"@value":"Shawn P. Williams"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01986325"},{"@type":"EISSN","@value":"10981128"}],"prism:publicationName":[{"@value":"Medicinal Research Reviews"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2006-09-29","prism:volume":"27","prism:number":"3","prism:startingPage":"374","prism:endingPage":"400"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.20083"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.20083"}],"createdAt":"2006-09-29","modifiedAt":"2023-11-15","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285706992235904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure–activity relationships and fluorescence properties"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181968814464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of 1,3-diphenyladamantane derivatives as nonsteroidal progesterone receptor antagonists"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204179104128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Novel Non-steroidal Progesterone Receptor Ligands Based on <i>m</i>-Carborane Containing a Secondary Alcohol: Effect of Chirality on Ligand Activity"},{"@value":"Highlighted Paper selected by Editor-in-Chief : Novel Non-steroidal Progesterone Receptor Ligands Based on m-Carborane Containing a Secondary Alcohol : Effect of Chirality on Ligand Activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282752375915904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of Boron-Cluster-Based Progesterone Receptor Antagonists Bearing a Pentafluorosulfanyl (SF<sub>5</sub>) Group"},{"@value":"Development of Boron-Cluster-Based Progesterone Receptor Antagonists Bearing a Pentafluorosulfanyl (SF₅) Group"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892096568704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Construction of reporter gene assays using CWP and PDR mutant yeasts for enhanced detection of various sex steroids"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/med.20083"},{"@type":"CROSSREF","@value":"10.1248/cpb.c17-00544_references_DOI_3cLnXOPUTvzhJH4ohY3tAQn78ti"},{"@type":"CROSSREF","@value":"10.1016/j.bmc.2016.09.020_references_DOI_3cLnXOPUTvzhJH4ohY3tAQn78ti"},{"@type":"CROSSREF","@value":"10.1186/s41021-020-00159-x_references_DOI_3cLnXOPUTvzhJH4ohY3tAQn78ti"},{"@type":"CROSSREF","@value":"10.1248/cpb.c19-00522_references_DOI_3cLnXOPUTvzhJH4ohY3tAQn78ti"},{"@type":"CROSSREF","@value":"10.1016/j.bmc.2014.12.047_references_DOI_3cLnXOPUTvzhJH4ohY3tAQn78ti"}]}